Filing Details
- Accession Number:
- 0001127602-23-008749
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-03 16:45:39
- Reporting Period:
- 2023-03-01
- Accepted Time:
- 2023-03-03 16:45:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 816956 | Conmed Corp | CNMD | Electromedical & Electrotherapeutic Apparatus (3845) | 160977505 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238334 | S Daniel Jonas | C/O Conmed Corp 11311 Concept Boulevard Largo FL 33773 | Special Counsel & Corp Secy | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-03-01 | 2,500 | $0.00 | 14,784 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-03-01 | 736 | $96.16 | 14,048 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2023-03-02 | 5,400 | $59.96 | 19,448 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-03-02 | 5,400 | $96.25 | 14,048 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-03-02 | 5,000 | $78.76 | 19,048 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-03-02 | 5,000 | $96.08 | 14,048 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Rsus (restricted Stock Units) | Disposition | 2023-03-01 | 2,500 | $0.00 | 2,500 | $0.00 |
| Common Stock | Rsus (restricted Stock Units) | Acquisiton | 2023-03-01 | 3,000 | $0.00 | 3,000 | $0.00 |
| Common Stock | Options To Purchase Common Stock | Disposition | 2023-03-02 | 5,400 | $0.00 | 5,400 | $59.96 |
| Common Stock | Options To Purchase Common Stock | Disposition | 2023-03-02 | 5,000 | $0.00 | 5,000 | $78.76 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2032-03-01 | No | 4 | M | Direct | |
| 3,000 | 2033-03-01 | No | 4 | A | Direct | |
| 0 | 2028-03-01 | No | 4 | M | Direct | |
| 5,000 | 2029-03-01 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.03 to $96.24. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting 100% after a one year period.
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting in equal amounts (1000 units) over a three year period.
- The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
- The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period
Billionaire Hedge Funds
